Filed: 11/14/2024ACC: 0001172661-24-004788
📋 What this filing means
SUVRETTA CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 98 equity positions with a total reported market value of $3.13B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
98
Positions
$3.13B
Total AUM (reported)
144.30M
Total Shares
Allocation by class
COM$1.96B62.6%
TR UNIT$315.57M10.1%
COM NEW$195.11M6.2%
CL A$183.57M5.9%
COM PAR $.01$119.41M3.8%
SPONSORED ADS$66.52M2.1%
COMMON STOCK$64.66M2.1%
Portfolio Concentration
Top 3$724.91M23.2%
4–10$666.18M21.3%
11–25$826.37M26.4%
Rest$907.97M29.1%
Top 3 weight
23.2%
Top 10 weight
44.5%
Voting Authority Distribution
Total shares with voting rights: 144.30M
Sole
Full voting authority
144.30M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole98
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings98
Rows:
SPDR S&P 500 ETF TR
SOLEShares550K
TypeSH
Market value$315.57M
10.10%
Sole
550K
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares5.20M
TypeSH
Market value$259.80M
8.31%
Sole
5.20M
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares7.65M
TypeSH
Market value$149.54M
4.78%
Sole
7.65M
Shared
0.00
None
0.00
INSMED INC
SOLEShares1.64M
TypeSH
Market value$119.41M
3.82%
Sole
1.64M
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares1.44M
TypeSH
Market value$105.29M
3.37%
Sole
1.44M
Shared
0.00
None
0.00
ARCUTIS BIOTHERAPEUTICS INC
SOLEShares10.72M
TypeSH
Market value$99.71M
3.19%
Sole
10.72M
Shared
0.00
None
0.00
META PLATFORMS INC
SOLEShares168.49K
TypeSH
Market value$96.45M
3.09%
Sole
168.49K
Shared
0.00
None
0.00
UNITEDHEALTH GROUP INC
SOLEShares146.84K
TypeSH
Market value$85.86M
2.75%
Sole
146.84K
Shared
0.00
None
0.00
BENITEC BIOPHARMA INC
SOLEShares8.83M
TypeSH
Market value$81.14M
2.60%
Sole
8.83M
Shared
0.00
None
0.00
APPLE INC
SOLEShares336.15K
TypeSH
Market value$78.32M
2.51%
Sole
336.15K
Shared
0.00
None
0.00
AMAZON COM INC
SOLEShares352.07K
TypeSH
Market value$65.60M
2.10%
Sole
352.07K
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
SOLEShares1.15M
TypeSH
Market value$63.96M
2.05%
Sole
1.15M
Shared
0.00
None
0.00
TAIWAN SEMICONDUCTOR MFG LTD
SOLEShares348.74K
TypeSH
Market value$60.57M
1.94%
Sole
348.74K
Shared
0.00
None
0.00
89BIO INC
SOLEShares7.99M
TypeSH
Market value$59.14M
1.89%
Sole
7.99M
Shared
0.00
None
0.00
APOLLO GLOBAL MGMT INC
SOLEShares465.05K
TypeSH
Market value$58.09M
1.86%
Sole
465.05K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares689.95K
TypeSH
Market value$57.62M
1.84%
Sole
689.95K
Shared
0.00
None
0.00
ADVANCED MICRO DEVICES INC
SOLEShares346.57K
TypeSH
Market value$56.87M
1.82%
Sole
346.57K
Shared
0.00
None
0.00
STARBUCKS CORP
SOLEShares550.31K
TypeSH
Market value$53.65M
1.72%
Sole
550.31K
Shared
0.00
None
0.00
GOLDMAN SACHS GROUP INC
SOLEShares108.31K
TypeSH
Market value$53.62M
1.72%
Sole
108.31K
Shared
0.00
None
0.00
ROYALTY PHARMA PLC
SOLEShares1.87M
TypeSH
Market value$52.80M
1.69%
Sole
1.87M
Shared
0.00
None
0.00
TESLA INC
SOLEShares193.84K
TypeSH
Market value$50.71M
1.62%
Sole
193.84K
Shared
0.00
None
0.00
AT&T INC
SOLEShares2.29M
TypeSH
Market value$50.28M
1.61%
Sole
2.29M
Shared
0.00
None
0.00
CRH PLC
SOLEShares538.89K
TypeSH
Market value$49.98M
1.60%
Sole
538.89K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares4.21M
TypeSH
Market value$48.78M
1.56%
Sole
4.21M
Shared
0.00
None
0.00
FERGUSON ENTERPRISES INC
SOLEShares225.21K
TypeSH
Market value$44.72M
1.43%
Sole
225.21K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR S&P 500 ETF TRSOLE | TR UNIT | 550K | SH | $315.57M 10.10% | 550K | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 5.20M | SH | $259.80M 8.31% | 5.20M | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 7.65M | SH | $149.54M 4.78% | 7.65M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 1.64M | SH | $119.41M 3.82% | 1.64M | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 1.44M | SH | $105.29M 3.37% | 1.44M | 0.00 | 0.00 |
ARCUTIS BIOTHERAPEUTICS INCSOLE | COM | 10.72M | SH | $99.71M 3.19% | 10.72M | 0.00 | 0.00 |
META PLATFORMS INCSOLE | CL A | 168.49K | SH | $96.45M 3.09% | 168.49K | 0.00 | 0.00 |
UNITEDHEALTH GROUP INCSOLE | COM | 146.84K | SH | $85.86M 2.75% | 146.84K | 0.00 | 0.00 |
BENITEC BIOPHARMA INCSOLE | COM NEW | 8.83M | SH | $81.14M 2.60% | 8.83M | 0.00 | 0.00 |
APPLE INCSOLE | COM | 336.15K | SH | $78.32M 2.51% | 336.15K | 0.00 | 0.00 |
AMAZON COM INCSOLE | COM | 352.07K | SH | $65.60M 2.10% | 352.07K | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INSOLE | COM | 1.15M | SH | $63.96M 2.05% | 1.15M | 0.00 | 0.00 |
TAIWAN SEMICONDUCTOR MFG LTDSOLE | SPONSORED ADS | 348.74K | SH | $60.57M 1.94% | 348.74K | 0.00 | 0.00 |
89BIO INCSOLE | COM | 7.99M | SH | $59.14M 1.89% | 7.99M | 0.00 | 0.00 |
APOLLO GLOBAL MGMT INCSOLE | COM | 465.05K | SH | $58.09M 1.86% | 465.05K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 689.95K | SH | $57.62M 1.84% | 689.95K | 0.00 | 0.00 |
ADVANCED MICRO DEVICES INCSOLE | COM | 346.57K | SH | $56.87M 1.82% | 346.57K | 0.00 | 0.00 |
STARBUCKS CORPSOLE | COM | 550.31K | SH | $53.65M 1.72% | 550.31K | 0.00 | 0.00 |
GOLDMAN SACHS GROUP INCSOLE | COM | 108.31K | SH | $53.62M 1.72% | 108.31K | 0.00 | 0.00 |
ROYALTY PHARMA PLCSOLE | SHS CLASS A | 1.87M | SH | $52.80M 1.69% | 1.87M | 0.00 | 0.00 |
TESLA INCSOLE | COM | 193.84K | SH | $50.71M 1.62% | 193.84K | 0.00 | 0.00 |
AT&T INCSOLE | COM | 2.29M | SH | $50.28M 1.61% | 2.29M | 0.00 | 0.00 |
CRH PLCSOLE | ORD | 538.89K | SH | $49.98M 1.60% | 538.89K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 4.21M | SH | $48.78M 1.56% | 4.21M | 0.00 | 0.00 |
FERGUSON ENTERPRISES INCSOLE | COMMON STOCK NEW | 225.21K | SH | $44.72M 1.43% | 225.21K | 0.00 | 0.00 |
Page 1 of 4